AZZ (AZZ) Receives News Sentiment Score of 0.06

Press coverage about AZZ (NYSE:AZZ) has trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. AZZ earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the industrial products company an impact score of 45.5447048974814 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

Shares of AZZ (AZZ) opened at $47.50 on Thursday. The firm has a market cap of $1,227.97, a price-to-earnings ratio of 24.01 and a beta of 1.55. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.57 and a quick ratio of 1.43. AZZ has a one year low of $43.17 and a one year high of $67.70.

AZZ (NYSE:AZZ) last announced its quarterly earnings results on Tuesday, October 3rd. The industrial products company reported $0.32 EPS for the quarter, missing the Zacks’ consensus estimate of $0.41 by ($0.09). The business had revenue of $190.40 million for the quarter, compared to the consensus estimate of $193.70 million. AZZ had a net margin of 6.27% and a return on equity of 9.65%. The business’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.55 EPS. analysts expect that AZZ will post 1.99 earnings per share for the current fiscal year.

Several analysts have recently weighed in on AZZ shares. BidaskClub lowered shares of AZZ from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 19th. Zacks Investment Research lowered shares of AZZ from a “hold” rating to a “strong sell” rating in a research note on Thursday, September 28th. Finally, Stifel Nicolaus lowered their price objective on shares of AZZ from $56.00 to $52.00 and set a “hold” rating for the company in a research note on Wednesday, September 27th.

TRADEMARK VIOLATION NOTICE: “AZZ (AZZ) Receives News Sentiment Score of 0.06” was reported by Zolmax and is owned by of Zolmax. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://zolmax.com/investing/azz-azz-receives-news-sentiment-score-of-0-06/1829286.html.

About AZZ

AZZ Inc is a provider of galvanizing services, welding solutions, specialty electrical equipment and engineered services to the power generation, transmission, distribution, refining and industrial markets. The Company operates through two segments: Energy segment and Galvanizing segment. Its Energy segment provides products and services designed to support industrial, nuclear and electrical applications.

Insider Buying and Selling by Quarter for AZZ (NYSE:AZZ)

Receive News & Ratings for AZZ Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AZZ Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Ingredion  Receiving Somewhat Positive News Coverage, Accern Reports
Ingredion Receiving Somewhat Positive News Coverage, Accern Reports
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact CF Industries  Stock Price
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact CF Industries Stock Price
Financial Comparison: Akari Therapeutics  & Sarepta Therapeutics
Financial Comparison: Akari Therapeutics & Sarepta Therapeutics
COCA-COLA HBC  Cut to “Sell” at Zacks Investment Research
COCA-COLA HBC Cut to “Sell” at Zacks Investment Research
Analyzing Cerus  & Its Peers
Analyzing Cerus & Its Peers
Merck & Co., Inc.  Receives Consensus Recommendation of “Hold” from Analysts
Merck & Co., Inc. Receives Consensus Recommendation of “Hold” from Analysts


Leave a Reply

 
© 2006-2017 Zolmax.